Stem cells translational medicine
| 短名 | STEM CELLS Transl Med |
| Journal Impact | 5.27 |
| 国际分区 | CELL & TISSUE ENGINEERING(Q1) |
| 期刊索引 | SCI Q1中科院 2 区 |
| ISSN | 2157-6564, 2157-6580 |
| h-index | 99 |
| 国内分区 | 医学(2区)医学细胞与组织工程(3区) |
STEM CELLS TRANSLATIONAL MEDICINE 是月刊、同行评审、主要是在线的开放获取期刊。STEM CELLS TRANSLATIONAL MEDICINE 致力于促进细胞在临床治疗中的应用。通过连接干细胞分子和生物学研究并帮助加快将实验室新发现转化为临床试验，STEM CELLS 转化医学将帮助这些关键研究的应用更接近公认的最佳患者实践，并最终改善结果。该杂志鼓励原创研究文章和描述干细胞实验室研究的简明评论，包括它们的表征和操作，以及从实验室到患者护理的临床方面的转化。 STEM CELLS 转化医学涵盖转化细胞研究的所有方面，包括基准研究、首次人体案例研究和相关临床试验。
期刊主页投稿网址| 涉及主题 | 生物遗传学医学细胞生物学内科学化学生物化学干细胞病理免疫学基因外科间充质干细胞细胞癌症研究体外内分泌学心理学胚胎干细胞 |
| 出版信息 | 出版商: Oxford University Press，出版周期: ，期刊类型: journal |
| 基本数据 | 创刊年份: 2012，原创研究文献占比: 70.75%，自引率:1.90%， Gold OA占比: 92.39% |
| 平均审稿周期 | 网友分享经验：较慢,6-12周 |
| 平均录用比例 | 网友分享经验：容易 |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Unraveling devitalization: its impact on immune response and ectopic bone remodeling from autologous and allogeneic callus mimics
2024-9-14
Decoded cardiopoietic cell secretome linkage to heart repair biosignature
2024-9-11
Cell-based therapy in the treatment of musculoskeletal diseases.
2024-9-3
Correction to: NLRP3 and AIM2 inflammasomes expression is modified by LPS and titanium ions increasing the release of active IL-1β in alveolar bone-derived MSCs
2024-8-26
Impact of compression forces on different mesenchymal stem cell types regarding orthodontic indication
2024-8-24
Abstract 26: Influence of Blood Type in Umbilical Cord Blood Immune Cell Profile
2024-8-21
Abstract 8: Facilitating Hematopoietic Cell Transplant for Patients with Infantile Krabbe Disease Identified by Newborn Screening
2024-8-21
Abstract 29: Utilizing Human Umbilical Cord Blood-Derived Exosomes for Inflammation Modulation and Tissue Regeneration: A Promising Therapeutic Strategy
2024-8-21
Abstract 9: No Evidence of Mycoplasma or Ureaplasma Contamination of Cord Blood Units Collected from at Term Mothers
2024-8-21
Abstract 27: Physiologic Oxygen Expansion Enhances Lymphocyte and Neutrophil Recovery Following Transplantation
2024-8-21
Abstract 10: Effect of Human Fetal Hemoglobin on Reactive Oxygen Species in DMSO Cryopreserved Cord Blood Progenitors Post Thaw
2024-8-21
Introduction: Cord Blood Connect 2024 Abstracts
2024-8-21
Abstract 25: During CB Transplant in MRD-Positive AML, Relapse is Usually Early, is Reduced by Acute GVHD and is Influenced by Ciclosporin Exposure: A Multicenter National Experience
2024-8-21
Abstract 1: A Brand-New Sourcing to Maximize Ethnic Diversity in Neonatal Stem Cell Collections and Correlated HLA Deep Understanding. Both to Improve Unrelated Cord Blood Units Inventory Efficiency and Biodata Based Drug Research
2024-8-21
Abstract 7: Influence of Long-term Storage of Cryopreserved Automated Volume-Reduced Cord Blood Units Until 20 Years: Analysis From Barcelona Cord Blood Bank, Spain.
2024-8-21
Abstract 23: Umbilical Cord Blood (CBU) Source as First Choice or as Rescue for Bone Marrow Transplant in Primary Immunodeficiencies (PID): A Single Center Experience
2024-8-21
Abstract 11: Multicomponent Cord Blood Bank Program, Beyond Transplantation
2024-8-21
Abstract 6: Value of a Multi-Regional Cord Blood Bank Program: Multiple Collection Centers to Select High-Quality Units for Transplantation
2024-8-21
Abstract 18: A Case of Successful Poor Graft Function Treatment with Wharton Jelly Mesenchymal Stem Cells
2024-8-21
Abstract 21: Feasibility of Harnessing Umbilical Cord Tissue for Alveolar Cleft Repair: A Collaboration between a Large Academic Institution and a Private Family Cord Blood Bank
2024-8-21
Abstract 28: Cord Blood Derived Macrophages Promote the Differentiation of Oligodendrocyte Precursor Cells
2024-8-21
Abstract 20: National Cord Blood Network Training Tool to Optimize Cord Blood Unit (CBU) Selection
2024-8-21
Abstract 12: Cord Blood Banking, Technical and Clinical grade GMP- Development of Advanced Therapy Products as HLA-Homozygous iPSC-derived Cardiomyocytes
2024-8-21
Abstract 4: Cord Blood Unit: Many Treatment Opportunities for Many Patients
2024-8-21
Abstract 31: Umbilical Cord Blood Derived Macrophages, DUOC-01, Suppress Neuroinflammation by Protecting the Blood Brain Barrier
2024-8-21
Abstract 13: Post-Thaw Clinic: Boosting Cord Utilisation by Supporting Clinical Teams
2024-8-21
Abstract 5: Decontamination of Two Umbilical Cord Blood Grafts Prior to Autologous Administration
2024-8-21
Abstract 19: Cord Blood HLA Diversity and Impact on Matching
2024-8-21
Abstract 32: Engineering Cord Blood CD34+ Cells for the Generation of Allogeneic NK or Myeloid Cell Immunotherapies
2024-8-21
Abstract 14: Contribution of US Public Cord Blood Banking to Improved Engraftment and Survival after Allogeneic Cord Blood Transplantation (CBT)
2024-8-21
Abstract 22: Autologous Cord Blood vs Personalised Supplements for Autistic Spectrum Disease – CORDUS Study
2024-8-21
Abstract 2: Reduction of Laboratory Supply Costs and Streamlining of Ordering Process
2024-8-21
Abstract 15: Invasive Aspergillus Niger Infection Cured after V Hematopoietic Stem Cell Transplantation in a Pediatric Patient with Severe Congenital Neutropenia
2024-8-21
Abstract 16: Tissue Engineering Approach Using Heterogeneous Hydrogel Combined with Umbilical Cord Derived Multipotent Stem Cells for the Consequences Military Spinal Cord Injury Neurosurgical Treatment (Case Report)
2024-8-21
Abstract 17: IL10R Deficiency and Hemopoietic Cell Transplantation (HCT): Outcome of 2 Patients Treated in a Single Center with CBU HCT
2024-8-21
Abstract 3: Adapting to Evolving Demands: Diversifying Cord Blood Processing to Mitigate Supply Chain and Vendor Risks
2024-8-21
Abstract 30: In-Depth Characterization of B-Lineage Populations Arising During Cord Blood CD34+ HSPC Differentiation for ETV6::RUNX1 Progenitor Identification
2024-8-21
Abstract 24: Granulocytes to Induce Donor-Derived T Cell Expansion after T Replete, Mismatched CB in Post-Transplant Relapsed and Refractory Paediatric Acute Leukaemia: Results of Grans Trial
2024-8-21
Abstract 33: Transcriptomic Identification of Functionally Potent Umbilical Cord Blood Units
2024-8-21
Efficacy and safety of mesenchymal stem cell therapies for ischemic stroke: a systematic review and meta-analysis
2024-8-19
Recent progress in modeling and treating diabetes using stem cell-derived islets
2024-8-19
Correction to: Amnion membrane hydrogel and amnion membrane powder accelerate wound healing in a full thickness porcine skin wound model
2024-8-10
Detection of residual pluripotent stem cells in cell therapy products utilizing droplet digital PCR: an international multisite evaluation study
2024-8-9
Improving the future of clinical trials and translation of mesenchymal stromal cell therapies for neonatal disorders
2024-8-9
Glutaminase-1 inhibition alleviates senescence of Wharton’s jelly-derived mesenchymal stem cells via senolysis
2024-8-9
A novel long noncoding RNA AK029592 contributes to thermogenic adipocyte differentiation
2024-8-8
Cryopreserved apoptotic mesenchymal stromal cells retain functional efficacy in suppressing an allergic inflammation in a murine model
2024-8-7
A detailed survey of the murine limbus, its stem cell distribution, and its boundaries with the cornea and conjunctiva
2024-7-30
Three-dimensional cultured human umbilical cord mesenchymal stem cells attenuate pulmonary fibrosis by improving the balance of mitochondrial fusion and fission
2024-7-30
Mitigation of supply chain challenges in cell therapy manufacturing: perspectives from the cord blood alliance
2024-7-29
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远